Prevalence, Reasons, and Determinants of Discharge Against Medical Advice Among Hospitalized Pediatric Patients at

Tesfaye Shumet Mekonnen1, Demewoz Fikir2

  • 1Department of Public Health College of Medicine and Health Sciences, Debre Markos University Debre Markos Ethiopia.

Health Science Reports
|August 18, 2026
PubMed

Insights

Discharge against medical advice (DAMA) affects nearly 10% of pediatric patients in Ethiopia. Higher maternal education significantly reduces DAMA rates, highlighting the role of caregiver knowledge in pediatric care decisions.

Area of Science:

  • Pediatric Healthcare
  • Public Health
  • Health Services Research

Background:

  • Discharge against medical advice (DAMA) presents a significant challenge in pediatric care, associated with adverse outcomes.
  • Limited evidence exists on the prevalence and determinants of pediatric DAMA in Ethiopia.
  • Understanding DAMA is crucial for improving pediatric patient management and outcomes in the region.

Purpose of the Study:

  • To determine the prevalence of pediatric DAMA at the University of Gondar Comprehensive Specialized Hospital (UGCSH).
  • To identify the primary reasons contributing to DAMA among pediatric patients.
  • To investigate factors associated with DAMA in pediatric admissions in Northwest Ethiopia.

Main Methods:

  • A prospective observational study was conducted with 422 pediatric patients from December 2024 to September 2025.
  • Data collection involved caregiver interviews and medical record reviews using a structured questionnaire.
  • Statistical analyses included descriptive statistics and multivariable logistic regression to identify associated factors.

Main Results:

  • The prevalence of DAMA was 9.7% among hospitalized pediatric patients.
  • Financial constraints, lack of clinical improvement, and perceived recovery were the leading reasons for DAMA.
  • Maternal education was significantly associated with DAMA; higher education levels correlated with lower DAMA odds.

Conclusions:

  • Nearly 10% of pediatric hospitalizations in the study area resulted in DAMA.
  • Maternal education emerged as a key factor influencing DAMA, underscoring the importance of socioeconomic and knowledge-based determinants.
  • Interventions focusing on caregiver education and enhanced hospital services are recommended to mitigate DAMA and improve pediatric outcomes.
Abstract

Related Concept Videos

Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...